Database
User
| Compound | Dose | Time | Species | Model | Method | Action | Result | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|---|
| Melittin | 5μM and 16μM | bovine | bovine heart MF1-ATPase | Positive | IC50 | 170 | |||
| Nimesulide | 1 mM | rat; Sprague-Dawley Crl:CD (SD) BR | lung microsomes | measurement of NADPH oxidation | increase | Positive | p < 0.05 | 11 | |
| IF1 | 0.25 μM | bovine | bovine heart MF1-ATPase | Positive | IC50 | 170 | |||
| IF1 | 1.2 μM | bovine | heart MF1-ATPase | Positive | IC50 | 170 | |||
| IF1 | 0.84 μM | bovine | heart MF1-ATPase | Positive | IC50 | 170 | |||
| IF1 | 300 μg/mg protein (T. pyriformis SMP-ATPase) ; | Positive | IC50 | 170 | |||||
| IF1 | 34 μg/mg protein | C. asciculate | SMP-ATPase | Positive | IC50 | 170 | |||
| IF1 | 0.24 μM | rat | liver MF1-ATPase | Positive | Ki | 170 | |||
| Enterostatin | Positive | 170 | |||||||
| ethyldimethylaminopropyl carbodiimide | 13 mol of EDC/mol F1 (EF1-ATPase) | Positive | 95% inhibition | 170 | |||||
| 1,5-difluoro-2,4-dinitrobenzene | Positive | 170 | |||||||
| Angiostatin | Positive | 170 | |||||||
| NBD-Cl | Positive | 170 | |||||||
| NBD-Cl | Positive | 170 | |||||||
| Gentamicin | 300 μg/ml | 1hr | postnatal day 6 (P6±1d) FVB mice | basal turn outer hair cells ( low-frequency processing OHCs) from intact cochlear (organ of Corti) explants | scanning confocal microscope (NADH autofluorescence); T1 imaging buffer contained 5 mM glucose. T2 imaging buffer contained 10 mM glucose, 3 mM glutamate and 2 mM pyruvate. | decrease | Positive | 312 | |
| Troglitazone | >25 µM | 1 and 2 hr | HepG2 cells | Cellular ATP concentrations were measured with a ATP Bioluminescent Somatic Cell Assay Kit | decrease | Positive | 332 | ||
| Amitriptyline | Positive | 197 | |||||||
| Desipramine | Positive | 197 | |||||||
| lumiracoxib | Positive | 197 | |||||||
| Berberine | 25 μM | 48, 72 hr | K1735-M2 mouse melanoma cells | An acid extraction procedure was used to evaluate the intracellular concentration of adenine nucleotides. Adenine nucleotides were separated by reverse-phase high-performance liquid chromatography. Quantification was achieved by employing ATP, ADP, and AMP standard curves. | decrease | Positive | p< 0.05 vs. control for each time of incubation | 327 | |
| Berberine | 10 μM | 24 hr | K1735-M2 mouse melanoma cells | An acid extraction procedure was used to evaluate the intracellular concentration of adenine nucleotides. Adenine nucleotides were separated by reverse-phase high-performance liquid chromatography. Quantification was achieved by employing ATP, ADP, and AMP standard curves. | decrease | Positive | p< 0.05 vs. control for each time of incubation | 327 | |
| buformin | 62.5 μM | 24 hours | human | HepG2 cells | Assay of Cellular ATP Content | decrease | Positive | p < 0.001 | 15 |
| buformin | 62.5 μM | 24 hours | human | HepG2 cells | Assay of Cellular ATP Content | decrease | Positive | p < 0.001 | 15 |
| Phenformin | 62.5 μM | 24 hours | human | HepG2 cells | Assay of Cellular ATP Content | decrease | Positive | p < 0.001 | 15 |
| Phenformin | 62.5 μM | 24 hours | human | HepG2 cells | Assay of Cellular ATP Content | decrease | Positive | p < 0.001 | 15 |
| Metformin | 657 μM | 24 hours | human | hepatocytes | Assay of Cellular ATP Content | decrease | Positive | IC50 | 15 |
| buformin | 26.1 μM | 24 hours | human | hepatocytes | Assay of Cellular ATP Content | decrease | Positive | IC50 | 15 |
| Phenformin | 11.7 μM | 24 hours | human | hepatocytes | Assay of Cellular ATP Content | decrease | Positive | IC50 | 15 |
| Metformin | 1430 μM | 24 hours | human | HepG2 cells | Assay of Cellular ATP Content | decrease | Positive | IC50 | 15 |
| buformin | 43.7 μM | 24 hours | human | HepG2 cells | Assay of Cellular ATP Content | decrease | Positive | IC50 | 15 |
| Phenformin | 12.9 μM | 24 hours | human | HepG2 cells | Assay of Cellular ATP Content | decrease | Positive | IC50 | 15 |
| Metformin | > 2000 μM | 24 hours | human | HepG2 cells | Assay of Cellular ATP Content | decrease | Positive | IC50 | 15 |
| buformin | > 500 μM | 24 hours | human | HepG2 cells | Assay of Cellular ATP Content | decrease | Positive | IC50 | 15 |
| Phenformin | > 500 μM | 24 hours | human | HepG2 cells | Assay of Cellular ATP Content | decrease | Positive | IC50 | 15 |
| Diazepam | 150μg/ml | 2hr | PE cells | luciferin-luciferase method | decrease | Positive | 293 | ||
| Troglitazone | human | hepatocytes | ATP bioluminescence assay | decrease | Positive | 226 | |||
| Diclofenac | 50 μmol/L | 10 minutes | rat | liver mitochondria | Measurement of Mitochondrial NADPH; incubated in the presence of Ca2+ | increase | Positive | p < 0.01 | 6 |
| Diclofenac | 250 μmol/L | 24 hours | rat | hepatocytes | Assay of Cellular ATP contents; Assay of LDH leakage | decrease | Positive | p < 0.01 | 6 |
| Diclofenac | 500 μmol/L | 24 hours | rat | hepatocytes | Assay of Cellular ATP contents; Assay of LDH leakage | decrease | Positive | p < 0.01 | 6 |